Jump to section
To increase the survival rate for sudden cardiac arrest (SCA) by proactively empowering people with reliable life-saving tools.
Few candidates hear
back within 2 weeks
Sudden Cardiac Arrest (SCA) is a leading cause of death in the US, taking the lives of over 350,000 people per year. Currently, the survival rate for SCA is extremely low, but chances rise substantially if treatment can be administered quickly.
Avive Solutions exists to support better survival rates for SCA. The idea is to supply normal people with the tools to save lives, by developing and supplying automated external defibrillators (AEDs). The company's machines, which are currently the most portable FDA-approved AEDs on the market, not only act as defibrillators but also connect to other devices for remote monitoring, and can communicate with 911.
With the ultimate vision that no witnessed SCA goes untreated, there is no denying that Avive's undertaking is a noble one. Its product has been recognised by the International Design Excellence Awards, and substantial growth funding will be used to build connected AED networks in cities that enable AEDs to be used on Sudden Cardiac Arrest cases well before emergency services can arrive on scene.
Steph
Company Specialist at Welcome to the Jungle
Apr 2024
$56.5m
LATE VC
Mar 2022
$22m
SERIES A
Sameer Jafri
(CEO)Founder and President of the Saving Hearts Foundation. Previously co-founded Twazer, and was a Clinical Research and Laboratory Assistant at Immunicom.
Rory Beyer
(President)Worked in Product Design at Apple. At MIT, worked on "Gecko Gloves" in the Microsystems Technology Laboratory. Also contributed to the development of a new wind turbine at Marenco Engineering Technologies Africa.
Moseley Andrews
(CTO)Studied Mechanical Engineering at MIT, and worked in the MIT Media Lab helping to develop novel sensing and imaging techniques prior to co-founding Avive Solutions.
Design
Sales & Account Management